Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
PlexusDx providers coordinate with your primary care physician to adjust concomitant medications and monitor for hypotension as weight loss accelerates
GLP-1 receptor agonists such as Saxenda and Wegovy work, with clinical trial evidence behind them roughly 6% and 16% body weight reduction respectively over 68-week trials
While using a medication from each class in combination does not pose a safety concern for patients, there is no evidence supporting additive efficacy with this combination
Effect of a Topical Collagen Tripeptide on Antiaging and Inhibition of Glycation of the Skin: A Pilot Study
More offers
Body Weight and Composition Your current body weight and composition are crucial determinants in establishing the right semaglutide dosage
